Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Clinical Evaluation of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) NX02-0018

ClinicalTrials.gov ID: NCT00945490

Public ClinicalTrials.gov record NCT00945490. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 4:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Phase III Multicenter Prospective Randomized Parallel-Group Placebo-Controlled Double Blind Clinical Evaluation of NX-1207 for the Treatment of BPH NX02-0018

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the safety and efficacy of a 2.5 mg dose of NX-1207 for the treatment of BPH (benign prostatic hyperplasia) as compared to placebo.

Study identification

NCT ID
NCT00945490
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Nymox Corporation
Industry
Enrollment
500 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
45 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2009 (Type not available)
Primary completion
May 2014 (Actual)
Completion
May 2014 (Actual)
Last update posted
Mar 10, 2017

2009 – 2014

United States locations

U.S. sites
35
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
For information concerning this clinical site, please contact Nymox at 800-936-9669. Laguna Hills California 92653 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. San Diego California 92103 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. San Diego California 92120 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Tarzana California 91356 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Torrance California 90505 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Denver Colorado 80220 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Englewood Colorado 80113 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Aventura Florida 33180 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Ocala Florida 34474 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Orlando Florida 32803 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Sarasota Florida 34237 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Meridian Idaho 83642 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Annapolis Maryland 21401 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Baltimore Maryland 21237 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Glen Burnie Maryland 21061 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Towson Maryland 21204 —
For information concerning this clinical site, please contact Nymox at 800-936-9669 Grand Rapids Michigan 49546 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Sartell Minnesota 56377 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Southaven Mississippi 38671 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Las Vegas Nevada 89146 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Las Vegas Nevada 89148 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Brick New Jersey 08724 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Albuquerque New Mexico 87109 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Albany New York 12208 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Garden City New York 11530 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. New York New York 10016 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Bismarck North Dakota 58501 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Oklahoma City Oklahoma 73104 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Bryn Mawr Pennsylvania 19010 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Sewickley Pennsylvania 15143 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Memphis Tennessee 38119 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Houston Texas 77024 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. McAllen Texas 78503 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. San Antonio Texas 78229 —
For information concerning this clinical site, please contact Nymox at 800-936-9669. Richmond Virginia 23235 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00945490, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 10, 2017 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00945490 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →